{"id":831964,"date":"2025-03-31T17:46:46","date_gmt":"2025-03-31T21:46:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/"},"modified":"2025-03-31T17:46:46","modified_gmt":"2025-03-31T21:46:46","slug":"oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/","title":{"rendered":"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March  31, 2025  (GLOBE NEWSWIRE) &#8212; ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in April:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Needham&#8217;s 24th Annual Healthcare Conference \u2013 <\/strong>Presenting a company overview on Monday, April 7, 2025, at 1:30 p.m. ET<\/li>\n<li style=\"text-align:justify\">\n          <strong>Stifel 2025 Virtual Targeted Oncology Forum \u2013 <\/strong>Participating in a fireside chat on Wednesday, April 9, 2025, at 2:00 p.m. ET<\/li>\n<\/ul>\n<p align=\"justify\">Webcasts of the presentation and discussion will be available through the investor section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KIKfP_eBPqEOLEvEBcXYIkbNMXderor4O8cmS28fkQPdf_8F4yWSgWAPxjpKi8v8HWMg8LcSGAptrBUn739VXxpZIgAb1sr3S3IrajBG41M=\" rel=\"nofollow\" target=\"_blank\"><u>www.oricpharma.com<\/u><\/a>. Replays of the webcasts will be available for 90 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About ORIC Pharmaceuticals, Inc. <\/strong><br \/>\n        <br \/>ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients\u2019 lives by\u00a0<em>Overcoming\u00a0Resistance\u00a0In\u00a0Cancer.\u00a0<\/em>ORIC\u2019s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC<sup>\u00ae<\/sup> is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KIKfP_eBPqEOLEvEBcXYIgDOIGWFFSlXqBpu4SevEdGydpkwvKwvvKFub8Ehn3Lb9BJVwxUeA0scl2dCloT45ObK-2Vnc4e8dC8_thSzoKiqscbogHSktP00ZM1mQOms-5bguJgmLhtCJyDngcHjm5m3I_8aezGg6gSwyB0Uxywi3eIZbFw41Hv-t3fpFd-GCWcvxY8Lq7_8lxqnSc8zuZ__ItuMzHbHzSTzKQybdoCCa0W2KtB2Dp8aOQJRC-S-kWMU6Nzyr4WAvmjnWSfa7g==\" rel=\"nofollow\" target=\"_blank\"><u>www.oricpharma.com<\/u><\/a>, and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k96pDciRojOwjzigcPIkq7kYL6iV6vSFFqilLpw9JbPTndAilYMeUIzKrqVKXAURMWqlCpfABKW3Set_BAEWjCeuA_g-olhW1A0tZjWyGO-QZWukVfSHg4RPbphwHmzzO2zzIYlY1Pye12ISZ_KxDziQ92AakAWHyLvtvpsMjwS3bz7gsxlGNaktUgLzPj8wTzgzZ2MoFfLPBoT8RkeLmQ==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a><u>\u00a0<\/u>or\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qh7vfSvx0tCdviM6iorl2YYglnE7ElxNeWWX73wwtQoPMIe5ST6tNn9ntK9Gq_BMJN4XHHJs6y3SAaHHdoFTN6QMrN-t5Sbcon6zFgvY1VPmmAFNl5Lumsml8IT8g8yEBO4xCdrd3RoJl80GeU3XiVhKbpcx7aKX4NdA4ejkZZVLLxY7l980-2gz1gjvmTZZVquv_t_yhXrV3FeOvQKWUAORcNcPvLC0tJTw1-h-0qlIdHBoYxxzG-u1Wrq-b_KazE-r39wz2oNrX7fn3r2V_A==\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Dominic Piscitelli, Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yxewTdBBCbuIf0dMXUSbBNrVmVIZbd3cnZMqKaNsjJeWKxdLDRhyo8P9nTzOinXhUVWg8B7SLfIftaeqdb6FA3pyuuRQHas-Pi0Xy3dwvod18Ei4mTItbFxIBlLJD2hersJhM_4wmkrHCZJExB-HBg==\" rel=\"nofollow\" target=\"_blank\"><u>dominic.piscitelli@oricpharma.com<\/u><\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bad260vdZibBzCSYIqtOiumyuvKl8rQa_HJytxEhfHyY1AzbpwJEVwPCPj3gEk9aAdYJ0r-3JSuk9LrJwSVlpClYHLXOfv2b8wCt0gbbZmo=\" rel=\"nofollow\" target=\"_blank\"><u>info@oricpharma.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmMzYzAyZTEtODdlNi00NTI0LTkxMGYtYmRhNzZjYTk5ODRkLTEwOTI0NTYtMjAyNS0wMy0zMS1lbg==\/tiny\/ORIC-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) &#8212; ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in April: Needham&#8217;s 24th Annual Healthcare Conference \u2013 Presenting a company overview on Monday, April 7, 2025, at 1:30 p.m. ET Stifel 2025 Virtual Targeted Oncology Forum \u2013 Participating in a fireside chat on Wednesday, April 9, 2025, at 2:00 p.m. ET Webcasts of the presentation and discussion will be available through the investor section of the company\u2019s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event. About ORIC &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-831964","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) &#8212; ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in April: Needham&#8217;s 24th Annual Healthcare Conference \u2013 Presenting a company overview on Monday, April 7, 2025, at 1:30 p.m. ET Stifel 2025 Virtual Targeted Oncology Forum \u2013 Participating in a fireside chat on Wednesday, April 9, 2025, at 2:00 p.m. ET Webcasts of the presentation and discussion will be available through the investor section of the company\u2019s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event. About ORIC &hellip; Continue reading &quot;ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-31T21:46:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2025-03-31T21:46:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/\"},\"wordCount\":249,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/\",\"name\":\"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=\",\"datePublished\":\"2025-03-31T21:46:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/","og_locale":"en_US","og_type":"article","og_title":"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) &#8212; ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in April: Needham&#8217;s 24th Annual Healthcare Conference \u2013 Presenting a company overview on Monday, April 7, 2025, at 1:30 p.m. ET Stifel 2025 Virtual Targeted Oncology Forum \u2013 Participating in a fireside chat on Wednesday, April 9, 2025, at 2:00 p.m. ET Webcasts of the presentation and discussion will be available through the investor section of the company\u2019s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event. About ORIC &hellip; Continue reading \"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-31T21:46:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences","datePublished":"2025-03-31T21:46:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/"},"wordCount":249,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/","name":"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=","datePublished":"2025-03-31T21:46:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMzQyMyM2ODQwOTgyIzIwODA4ODU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-10\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ORIC\u00ae Pharmaceuticals to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/831964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=831964"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/831964\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=831964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=831964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=831964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}